Global Medical Device Contract Manufacturing Market to reach USD 79,333.13 million in 2024 at a CAGR of 12.01% by 2032, Evaluates DelveInsight

According to DelveInsight's analysis, The increasing prevalence of chronic and infectious diseases is fueling a steady demand for innovative, high-quality medical devices, prompting companies to accelerate their development initiatives. In response, leading medical device firms are boosting R&D investments and partnering with Contract Manufacturing Organizations (CMOs) to lower costs and shorten time-to-market. Alongside rapid technological advancements, this trend is driving a strong global pipeline of medical devices and facilitating regulatory approvals.

DelveInsight's "Medical Device Contract Manufacturing Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Medical Device Contract Manufacturing companies actively working in the market.

To know more about why North America is leading the market growth in the Medical Device Contract Manufacturing market, get a snapshot of the report Medical Device Contract Manufacturing Market Trends
https://www.delveinsight.com/sample-request/medical-device-contract-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Medical Device Contract Manufacturing Overview
Medical device contract manufacturing is the process where a company outsources the production of medical devices or components to a specialized third-party manufacturer. These contract manufacturers provide services such as design, prototyping, production, assembly, packaging, and regulatory support, ensuring compliance with healthcare standards

DelveInsight Analysis: The global medical device contract manufacturing market size was valued at USD 79,333.13 million in 2024 and is projected to grow at a CAGR of 12.01% between 2025 and 2032, reaching approximately USD 195,729.8 million by 2032.

Medical Device Contract Manufacturing Market Insights
Geographically, North America is expected to hold the largest share of the medical device contract manufacturing market in 2024. This leadership is driven by the rising prevalence of chronic diseases, the strong presence of established medical device companies, advanced healthcare infrastructure, and a comprehensive regulatory framework. The region benefits from high healthcare expenditure, an expanding elderly population, and sustained demand for innovative, high-quality devices. Furthermore, access to skilled workforce, state-of-the-art manufacturing technologies, and significant R&D investments positions North America as a key hub for outsourced medical device production, maintaining its leading role in the global market.

To read more about the latest highlights related to Medical Device Contract Manufacturing, get a snapshot of the key highlights entailed in the Medical Device Contract Manufacturing
https://www.delveinsight.com/report-store/medical-device-contract-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Medical Device Contract Manufacturing Market Report
• In June 2025, DuPont announced that it has entered into an agreement to acquire Donatelle Plastics Incorporated, a prominent medical device contract manufacturer specializing in the design, development, and production of medical components and devices. The deal is expected to close in the third quarter of 2024, pending customary closing conditions and regulatory approvals.
• In May 2025, Quasar Medical broadened its capabilities through the acquisition of Nordson's contract manufacturing division, strengthening its manufacturing services within the medical device industry.
• In May 2025, Boyd Biomedical introduced an end-to-end service model covering everything from design to product launch and inaugurated a new facility in Waltham, Massachusetts to support comprehensive device commercialization.
• In February 2025, Artereex, a prominent global medical device developer and contract manufacturer, announced the acquisition of Phoenix S.r.l., a Europe-based medical device company with a significant international footprint. The financial terms of the deal were not disclosed.
• Thus, owing to such developments in the market, rapid growth will be observed in the Medical Device Contract Manufacturing market during the forecast period

Key Players in the Medical Device Contract Manufacturing Market
Some of the key market players operating in the Medical Device Contract Manufacturing market include- Flex, Ltd., Integer Holdings Corporation, Gerresheimer AG, Sanmina Corporation, Nipro Corporation, Celestica International Ltd., Plexus Corp., Benchmark Electronics Inc., West Pharmaceutical Services, Inc., Jabil Inc., Tecomet Inc., Nortech Systems Inc., TE Connectivity, Forefront Medical Technologies, Nordson Corporation, and others.

Which MedTech key players in the Medical Device Contract Manufacturing market are set to emerge as the trendsetter explore @ Key Medical Device Contract Manufacturing Companies
https://www.delveinsight.com/sample-request/medical-device-contract-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Medical Device Contract Manufacturing Market Landscape
Moreover, strategic initiatives by leading medical device companies are expected to drive revenue growth in the healthcare contract manufacturing market. For instance, in July 2024, DuPont announced the completion of its previously disclosed acquisition of Donatelle Plastics, a well-known medical device contract manufacturer specializing in the production of advanced medical components and devices.
However, despite these growth drivers, the medical device contract manufacturing services market faces challenges. Strict regulatory requirements for product approval, supply chain management issues, and the need for substantial capital investment to balance capacity may constrain market growth during the forecast period.

Scope of the Medical Device Contract Manufacturing Market Report
• Coverage: Global
• Study Period: 2022-2032
• Medical Device Contract Manufacturing Market Segmentation By Device Type: IVD Devices, Drug Delivery Devices, Diagnostic Imaging Devices, Patient Monitoring Devices, Cardiovascular Devices, Orthopedic Devices, and Others
• Medical Device Contract Manufacturing Market Segmentation By Service: Device Development and Manufacturing Services, Quality Management Services, and Final Goods Assembly Services
• Medical Device Contract Manufacturing Market Segmentation By Application: Laparoscopy, Pulmonary, Urology & Gynecology, Cardiovascular devices, Orthopedic devices, and others
• Medical Device Contract Manufacturing Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Medical Device Contract Manufacturing Companies: Flex, Ltd., Integer Holdings Corporation, Gerresheimer AG, Sanmina Corporation, Nipro Corporation, Celestica International Ltd., Plexus Corp., Benchmark Electronics Inc., West Pharmaceutical Services, Inc., Jabil Inc., Tecomet Inc., Nortech Systems Inc., TE Connectivity, Forefront Medical Technologies, Nordson Corporation, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Medical Device Contract Manufacturing market will grow by 2032? Click to get a snapshot of the Medical Device Contract Manufacturing Market Analysis
https://www.delveinsight.com/sample-request/medical-device-contract-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.